Strata Critical Medical, Inc., trading under the ticker EXPC, filed an 8-K with the SEC on June 3, 2026, marking a notable disclosure event for the company in the critical-care medical technology sector. EXPC traces its origins to a blank-check special purpose acquisition company that completed its IPO in 2021, targeting opportunities in the healthcare and life sciences space. The company is currently in an active post-combination phase, operating under the Strata Critical Medical name following its business combination. The filing reflects ongoing reporting obligations as the company pursues its strategy in the medical device and critical-care market. Visit SpacDesk and sign up for full data, filings history, and real-time alerts on EXPC and hundreds of other SPAC-related names.